Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CPBIO Holding CoCAIHF 58 Graham Number is $1.78 as of Mar. 2026. GuruFocus rates CAIHF with a GF Score™ of 58/100 and a GF Value™ of $0.16 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 599 Drug Manufacturers companies, CPBIO Holding Co ranks better than 84.81% on this metric.
Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.
As of today (2026-08-31), the stock price of CPBIO Holding Co is $1.0677. CPBIO Holding Co's graham number for the quarter that ended in Mar. 2026 was $1.78. Therefore, CPBIO Holding Co's Price to Graham Number ratio for today is 0.67.
The historical rank and industry rank for CPBIO Holding Co's Graham Number or its related term are showing as below:
CAIHF'
s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.17 Med: 0.5 Max: 1.35
Current: 0.69
During the past 12 years, the highest Price to Graham Number ratio of CPBIO Holding Co was 1.35. The lowest was 0.17. And the median was 0.50.
CAIHF's Price-to-Graham-Number is ranked better than 84.81% of 599
companies
in the Drug Manufacturers industry
Industry Median: 1.58
vs CAIHF: 0.69
Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.
CPBIO Holding Co (OTCPK:CAIHF) Graham Number Explanation
Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:
Current price should not be more than 15 times average earnings of the past three years.
Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)
Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.
In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.
CPBIO Holding Co's Price to Graham number Ratio for today is calculated as
Price to Graham number
=
Share Price (Today)
/
Graham number (Q: Mar. 2026 )
=
1.0677
/
1.60
=
0.67
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Please keep these in mind:
1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.
CPBIO Holding Co Graham Number Related Terms
CPBIO Holding Co Graham Number Historical Data
* Premium members only.
The historical data trend for CPBIO Holding Co's Graham Number can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, CPBIO Holding Co's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CPBIO Holding Co Price-to-Graham-Number vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CPBIO Holding Co's Price-to-Graham-Number distribution charts can be found below:
* The bar in red indicates where CPBIO Holding Co's Price-to-Graham-Number falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CPBIO Holding Co (CAIHF) has a Graham Number of $1.78 as of Mar. 2026. The Graham Number values a company based on its per-share earnings and book value. View historical data on CPBIO Holding Co and its competitors. According to the industry distribution chart, CPBIO Holding Co ranks #91 out of 599 companies in the Drug Manufacturers industry, placing it in the top 15.2%.
Is CPBIO Holding Co's Graham Number too high?
CPBIO Holding Co's current Graham Number is $1.78. The Drug Manufacturers industry median Graham Number is 1.58. CPBIO Holding Co's value of $1.78 is 12.7% above this industry median. Based on the distribution chart, CPBIO Holding Co ranks #91 out of 599 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, CPBIO Holding Co has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CPBIO Holding Co's Graham Number compare to ZTS?
According to the Drug Manufacturers industry distribution chart, CPBIO Holding Co ranks #91 out of 599 companies for Graham Number. This places CPBIO Holding Co in the top 15% of its industry — outperforming the majority of peers. The industry median Graham Number is 1.58. CPBIO Holding Co's value of $1.78 is 12.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Drug Manufacturers company?
The median Graham Number among Drug Manufacturers companies is 1.58, based on 599 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CPBIO Holding Co's current Graham Number of $1.78 is 12.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on CPBIO Holding Co and its competitors. For the Drug Manufacturers industry, the median Graham Number is 1.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CPBIO Holding Co's current Graham Number is $1.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CPBIO Holding Co stock overvalued right now?
Based on GuruFocus' analysis, CPBIO Holding Co (CAIHF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.16, compared to a current price of $1.07 — trading 567.3% above its estimated fair value. The current Graham Number is $1.78 and 12.7% above the Drug Manufacturers industry median of 1.58. CPBIO Holding Co's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For CPBIO Holding Co (CAIHF), the current Graham Number is $1.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CPBIO Holding Co (CAIHF) Overvalued in 2026?
Based on GuruFocus' analysis, CPBIO Holding Co stock appears to be overvalued.
The current stock price of $1.07 is trading 567.3% above its estimated GF Value™ of $0.16.
GuruFocus considers CPBIO Holding Co to be Significantly Overvalued.
Key valuation signals for CAIHF:
Graham Number: $1.78
GF Value™: $0.16 vs. price of $1.07 (567.3% above fair value)
Industry Position: 12.7% above the Drug Manufacturers median (#91 of 599)
No single metric tells the full story. See the CAIHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of animal health products and chlortetracycline (CTC). The group has two reportable segments: Biotech Business and Investment Business. The Biotech Business segment is involved in the manufacture and/or sale of animal health products and chlortetracycline. The Investment Business segment is engaged in the trading of machinery and the manufacture and sale of automotive parts through the group's joint ventures and associates. It generates the majority of its revenue from the Biotech Business segment. Its geographical segments are Mainland China, which generates key revenue, Asia Pacific (excluding mainland China), the Americas, Europe, and Others.
58GF Score
Get the complete analysis for CAIHF
Graham Number is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAIHF has been successfully added to your 
